Terms: = Thyroid cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
85 results:
1. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-met in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
2. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
3. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract] [Full Text] [Related]
4. [The thyroid cancer in children and adolescents: about 22 cases].
Anajar S; Tatari MM; Lakhbal A; Abada R; Rouadi S; Roubal M; Mahtar M
Pan Afr Med J; 2023; 46():9. PubMed ID: 37928225
[TBL] [Abstract] [Full Text] [Related]
5. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.
Chen D; Li L; Wang M; Hu X; Jiang J; Li W; Yang L; Fan M; Shi Y; Lv F; Liu Y
Front Immunol; 2023; 14():1086479. PubMed ID: 37795095
[TBL] [Abstract] [Full Text] [Related]
7. A Prospective Multicenter Study Examining the Relationship Between thyroid cancer Treatment Outcomes and the Presence of Autoimmune thyroiditis.
De Leo S; D'Elia S; Grani G; Dondi F; Bertagna F; Puxeddu E; Morelli S; Piovesan A; Nervo A; Zatelli MC; Gagliardi I; Samà MT; Aimaretti G; Crocetti U; Massa M; Deandrea M; Retta F; Pagano L; Rossi M; Solaroli E; Pezzullo L; Chiofalo MG; Pontecorvi A; Lombardi CP; Antonelli A; Patrizio A; Messuti I; Magri F; Spiazzi G; Ceresini G; Bruno R; Sparano C; Centanni M; Crescenzi A; Tallini G; Marotta V; Madeo B; Mian C; Filetti S; Durante C; Fugazzola L
Thyroid; 2023 Nov; 33(11):1318-1326. PubMed ID: 37725571
[No Abstract] [Full Text] [Related]
8. Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast cancer Society Clinical Practice Guideline, 2022 edition.
Nomura T; Kawai M; Fukuma Y; Koike Y; Ozaki S; Iwasaki M; Yamamoto S; Takamatsu K; Okamura H; Arai M; Ootani S; Iwata H; Saji S
Breast Cancer; 2023 Jul; 30(4):519-530. PubMed ID: 37029889
[TBL] [Abstract] [Full Text] [Related]
9. A Novel Glycolysis-Related Signature for Predicting the prognosis and Immune Infiltration of Uveal Melanoma.
Guo X; Yu X; Zhang Y; Luo H; Huang R; Zeng Y; Duan C; Chen C
Ophthalmic Res; 2023; 66(1):692-705. PubMed ID: 36858025
[TBL] [Abstract] [Full Text] [Related]
10. A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?
Su J; Lu J; Zhang J; Wang M; Yan J; Lin S
Curr Opin Oncol; 2023 Mar; 35(2):132-144. PubMed ID: 36721897
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Features and prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study.
Liu J; Gan M; Lin Z; Deng Q; Deng J; Zeng B; Shi Y; Ming J
Breast J; 2022; 2022():5469163. PubMed ID: 36531979
[TBL] [Abstract] [Full Text] [Related]
12. Primary squamous cell carcinoma of thyroid gland: 11 case reports and a population-based study.
Yan W; Chen H; Li J; Zhou R; Su J
World J Surg Oncol; 2022 Nov; 20(1):352. PubMed ID: 36329478
[TBL] [Abstract] [Full Text] [Related]
13. Circulating microRNAs and Clinicopathological Findings of Papillary thyroid cancer: A Systematic Review.
Geropoulos G; Psarras K; Papaioannou M; Giannis D; Meitanidou M; Kapriniotis K; Symeonidis N; Pavlidis ET; Pavlidis TE; Sapalidis K; Ahmed NM; Abdel-Aziz TE; Eddama MMR
In Vivo; 2022; 36(4):1551-1569. PubMed ID: 35738604
[TBL] [Abstract] [Full Text] [Related]
14. Impact of Patient Navigation on Population-Based Breast Screening: a Systematic Review and meta-analysis of Randomized Clinical Trials.
Tian L; Huang L; Liu J; Li X; Ajmal A; Ajmal M; Yao Y; Tian L
J Gen Intern Med; 2022 Aug; 37(11):2811-2820. PubMed ID: 35650466
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and risk of hypertension with lenvatinib in treatment of solid tumors: An updated systematic review and meta-analysis.
Wu H; Ding X; Zhang Y; Li W; Chen J
J Clin Hypertens (Greenwich); 2022 Jun; 24(6):667-676. PubMed ID: 35538636
[TBL] [Abstract] [Full Text] [Related]
16. Sentinel Lymph Node Biopsy after Previous Radical Lymphadenectomy of the Same Lymph Node Basin.
Wainstein AJA; Cândido LD; Drummond-Lage AP
J Invest Surg; 2022 May; 35(5):1171-1175. PubMed ID: 35168453
[No Abstract] [Full Text] [Related]
17. Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes.
Luo X; Huang X; Liu S; Wang X; Luo J; Xiao J; Wang K; Qu Y; Chen X; Zhang Y; Wang J; Zhang J; Xu G; Gao L; Wu R; Yi J
Cancer Med; 2022 Feb; 11(4):1059-1067. PubMed ID: 35080148
[TBL] [Abstract] [Full Text] [Related]
18. Apatinib vs Placebo in Patients With Locally Advanced or metastatic, Radioactive Iodine-Refractory Differentiated thyroid cancer: The REALITY Randomized Clinical Trial.
Lin Y; Qin S; Li Z; Yang H; Fu W; Li S; Chen W; Gao Z; Miao W; Xu H; Zhang Q; Zhao X; Bao J; Li L; Ren Y; Lin C; Jing S; Ma Q; Liang J; Chen G; Zhang H; Zhang Y; Zhou X; Sang Y; Hou Z
JAMA Oncol; 2022 Feb; 8(2):242-250. PubMed ID: 34913959
[TBL] [Abstract] [Full Text] [Related]
19. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
Coquan E; Brachet PE; Licaj I; Leconte A; Castera M; Lequesne J; Meriaux E; Bonnet I; Lelaidier A; Clarisse B; Joly F
BMC Cancer; 2021 Sep; 21(1):1054. PubMed ID: 34563169
[TBL] [Abstract] [Full Text] [Related]
20. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary thyroid Carcinoma.
Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
[TBL] [Abstract] [Full Text] [Related]
[Next]
